Justin West is a physician and father of three. His youngest son, Andrew, was diagnosed with KCNT1-related epilepsy at 9 months of age. He is director of clinical medicine at the KCNT1 Epilepsy Foundation, working with researchers and industry to identify and evaluate potential therapeutics.
Justin West
President and director of clinical medicine
KCNT1 Epilepsy Foundation
From this contributor
Progress amid setbacks in drug trials for rare forms of epilepsy: Q&A with Justin West
Despite grave side effects, it’s vital to keep developing treatments for rare genetic forms of childhood epilepsy, says West, president of the KCNT1 Epilepsy Foundation and father of a son with the condition.
Progress amid setbacks in drug trials for rare forms of epilepsy: Q&A with Justin West
By
Calli McMurray
30 August 2023 | 6 min read
Explore more from The Transmitter
Reverse engineering neural circuits; success stories from computational neuroscience
Kevin Mitchell talks with Timothy Behrens about ring attractors, the role of innate structure, and an expanded view of cognitive maps.
Reverse engineering neural circuits; success stories from computational neuroscience
Kevin Mitchell talks with Timothy Behrens about ring attractors, the role of innate structure, and an expanded view of cognitive maps.
By
Kevin Mitchell
6 August 2026 | 60 min watch
Alison Barth discovers how different neuron types contribute to cortical function
Barth uses learning tasks in mice as a tool to drive synaptic plasticity in the sensory cortex, hoping to unlock more general principles of how the cortex works.
Alison Barth discovers how different neuron types contribute to cortical function
Barth uses learning tasks in mice as a tool to drive synaptic plasticity in the sensory cortex, hoping to unlock more general principles of how the cortex works.
By
Paul Middlebrooks
5 August 2026 | 1 min read
Virus-like particles deliver gene-editing tools into Duchenne mouse model
The approach uses a protein found in fruit flies to ferry the gene editor Cas9 into muscle cells.
Virus-like particles deliver gene-editing tools into Duchenne mouse model
The approach uses a protein found in fruit flies to ferry the gene editor Cas9 into muscle cells.
By
Brianna Abbott
5 August 2026 | 5 min read